A new role for public health in bioterrorism deterrence

Frontiers in Public Health

Volumn 2, Issue DEC, 2014, Pages

  Kosal, Margaret E ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Biosecurity; Bioterrorism; Bioweapons; Deterrence; Ebola; National security; Polio; Public health

Indexed keywords

EID: 85020965057     PISSN: None     EISSN: 22962565     Source Type: Journal    
DOI: 10.3389/fpubh.2014.00278     Document Type: Note

References (34)

1. Ostfield M. Pathogen security: the illusion of security in foreign policy and biodefense. Int J Risk Assess Manag (2009) 12:205-10. doi:10.1504/ IJRAM.2009.025919
2. National Strategy for Countering Biological Threats. Washington, DC (2009). Available from: www.whitehouse.gov/sites/default/les/National_ Strategy_for_Countering_BioThreats.pdf
3. National Strategy for Biosurveillance. Washing-ton, DC (2012). Available from: http://www. whitehouse.gov/sites/default/files/National_ Strategy_for_Biosurveillance:July_2012.pdf
4. United States Government Policy for Oversight of Life Sciences Dual Use Research of Concern (2012). Available from: http://www.phe.gov/s3/dualuse/ Documents/us-policy-durc-032812.pdf
5. Public Health Security and Bioterrorism Prepared-ness and Response Act of 2002, Public Law 107-188 (2002). Available from: http://www.gpo.gov/fdsys/ pkg/PLAW-107publ188/pdf/PLAW-107publ188. pdf
6. Department of Defense Strategy for Countering Weapons of Mass Destruction. Washington, DC (2014). Available from: http://www.defense.gov/ pubs/DoD_Strategy_for_Countering_Weapons_ of_Mass_Destruction_dated_June_2014.pdf
7. Atlas RM. Combating the threat of biowarfare and bioterrorism: defending against biological weapons is critical to global security. Bioscience (1999) 49:465-77. doi:10.2307/1313554
8. Hamburg MA. Bioterrorism: a challenge to pub-lic health and medicine. J Public Health Manag Pract (2000) 6:38-44. doi:10.1097/00124784-200006040-00007
9. Khan AS,Morse S, Lillibridge S. Public-health pre-paredness for biological terrorism in the USA. Lancet (2000) 356:1179-82. doi:10.1016/S0140-6736(00)02769-0
10. Schelling TC. Arms and Influence. NewHaven,CO: Yale University Press (1966).
11. Knopf JW. The fourth wave in deterrence research. Contemp Secur Pol (2010) 31:1-33. doi:10.1080/ 13523261003640819
12. Kosal ME, Finnel S. The role of ethical dis-course in the contested common of radical Islam & WMD terrorism. Paper Presented at the Annual Meeting of the International Studies Association Annual Conference Global Governance. Montreal, QC: Political Authority in Transition (2011).
13. Hashmi SH, Lee SP. Ethics and Weapons of Mass Destruction. Cambridge, UK: Cambridge Univer-sity Press (2004). 552 p.
14. Trager RF, Zagorcheva DP. Deterring terrorism: it can be done. Int Secur (2006) 30:87-123. doi:10. 1162/isec.2005.30.3.87
15. Levine DK, Levine RA. Deterrence in the cold war and the 'War on Terror'. Defence Peace Econ (2006) 17:605-17. doi:10.1080/10242690601025526
16. Davis K, Jenkins BM. Deterrence and Influence in Counterterrorism: A Component in the War on al Qaeda. Santa Monica, CA: RAND (2002). 109 p.
17. Joseph RG, Reichart JF. Deterrence and Defense in a Nuclear, Biological, and Chemical Environ-ment. Washington, DC: National Defense Univer-sity Press (1999). 44 p.
18. Koblentz G. Pathogens as weapons: the inter-national security implications of biological war-fare. Int Secur (2003) 28:84-122. doi:10.1162/ 016228803773100084
19. Galamas F. Biological weapons, nuclear weapons and deterrence: the biotechnology revolution. Comp Strat (2008) 27:315-23. doi:10.1080/ 01495930802358364
20. Martin S. The role of biological weapons in inter-national politics. J Strat Stud (2002) 25:63-98. doi:10.1080/714004040
21. Fine PE. Herd immunity: history, theory, practice. Epidemiol Rev (1993) 15:265-302.
22. Eisenberg JNS, Brookhart MA, Rice G, Brown M, Colford JM Jr. Disease transmission models for public health decision making: analysis of epi-demic and endemic conditions caused by water-borne pathogens. Environ Health Perspect (2002) 110:783-90. doi:10.1289/ehp.02110783
23. Halloran ME, Longini IM Jr, Nizam A, Yang Y. Containing bioterrorist smallpox. Science (2002) 298:1428-32. doi:10.1126/science.1074674
24. Bozzette SA, Boer R, Bhatnagar V, Brower JL, Keeler EB, Morton SC, et al. A model for a smallpox-vaccination policy. N Engl J Med (2003) 348:416-25. doi:10.1056/NEJMsa025075
25. Meltzer MI, Damon I, LeDuc JW, Millar JD. Modeling potential responses to smallpox as a bioterrorist weapon, appendix I: a mathematical review of the transmission of smallpox. Emerg Infect Dis (2001) 7:i-vi. doi:10.3201/eid0706. 010607
26. Gani R, Leach S. Epidemiological determinants for modeling pneumonic plague outbreaks. Emerg Infect Dis (2004) 10:608-14. doi:10.3201/eid1004. 030509
27. Kool JL. Risk of person-to-person transmission of pneumonic plague. Clin Infect Dis (2005) 40:1166-72. doi:10.1086/428617
28. Chowell G, Hengartner NW, Castillo-Chavez C, Fenimore PW, Hyman JM. The basic reproduc-tive number of Ebola and the effects of public health measures: the cases of Congo and Uganda. J Theor Biol (2004) 229:119-26. doi:10.1016/j.jtbi. 2004.03.006
29. NishiuraH,ChowellG. Early transmission dynam-ics of Ebola virus disease (EVD), West Africa, March to August 2014. Euro Surveill (2014) 19(36):20894. doi:10.2807/1560-7917.es2014.19. 36.20894
30. Samba E, Nkrumah F, Leke R. Getting polio eradication back on track in Nigeria. N Engl J Med (2004) 350:645-6. doi:10.1056/NEJMp038210
31. Minor PD. Polio eradication, cessation of vaccina-tion and re-emergence of disease. Nat Rev Micro-biol (2004) 2:473-82. doi:10.1038/nrmicro906
32. Pallansch MA, Sandhu HS. The eradication of polio -progress and challenges. N Engl J Med (2006) 355:2508-11. doi:10.1056/NEJMp068200
33. Arie S. Polio virus spreads from Syria to Iraq. BMJ (2014) 348:g2481. doi:10.1136/bmj.g2481
34. Boozary AS, Farmer PE, Jha AK. The Ebola outbreak, fragile health systems, and quality as a cure. JAMA (2014) 312:1859-60. doi:10.1001/ jama.2014.14387